Last reviewed · How we verify
FS-67 Patch
At a glance
| Generic name | FS-67 Patch |
|---|---|
| Also known as | Topical Patch |
| Sponsor | Hisamitsu Pharmaceutical Co., Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
- Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia. (PHASE3)
- Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study (EARLY_PHASE1)
- Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children (PHASE3)
- Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP (NA)
- Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome (PHASE3)
- Topographical Distribution of Itch and Pain Receptors (NA)
- To Check Dermatological Safety of Test Products by 24 Hours Patch Testing (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |